Authors
- Khalid H. Sait, From the Gynecology Oncology Unit, Obstetrics and Gynecology Department (Sait K, Sait H, Anfinan), form the Faculty of Medicine (Sait K, Sait H, Sait M), King Abdulaziz University; and from the Stem cell Unit Oncology Unit, Department of Medical Laboratory Technology (Alam, Haque), King Fahd Medical Research Center and Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
- Mohammad Z. Alam, From the Gynecology Oncology Unit, Obstetrics and Gynecology Department (Sait K, Sait H, Anfinan), form the Faculty of Medicine (Sait K, Sait H, Sait M), King Abdulaziz University; and from the Stem cell Unit Oncology Unit, Department of Medical Laboratory Technology (Alam, Haque), King Fahd Medical Research Center and Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
- Absarul Haque, From the Gynecology Oncology Unit, Obstetrics and Gynecology Department (Sait K, Sait H, Anfinan), form the Faculty of Medicine (Sait K, Sait H, Sait M), King Abdulaziz University; and from the Stem cell Unit Oncology Unit, Department of Medical Laboratory Technology (Alam, Haque), King Fahd Medical Research Center and Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
- Hesham K. Sait, From the Gynecology Oncology Unit, Obstetrics and Gynecology Department (Sait K, Sait H, Anfinan), form the Faculty of Medicine (Sait K, Sait H, Sait M), King Abdulaziz University; and from the Stem cell Unit Oncology Unit, Department of Medical Laboratory Technology (Alam, Haque), King Fahd Medical Research Center and Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
- Maram K. Sait, From the Gynecology Oncology Unit, Obstetrics and Gynecology Department (Sait K, Sait H, Anfinan), form the Faculty of Medicine (Sait K, Sait H, Sait M), King Abdulaziz University; and from the Stem cell Unit Oncology Unit, Department of Medical Laboratory Technology (Alam, Haque), King Fahd Medical Research Center and Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
- Nisreen M. Anfinan, From the Gynecology Oncology Unit, Obstetrics and Gynecology Department (Sait K, Sait H, Anfinan), form the Faculty of Medicine (Sait K, Sait H, Sait M), King Abdulaziz University; and from the Stem cell Unit Oncology Unit, Department of Medical Laboratory Technology (Alam, Haque), King Fahd Medical Research Center and Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Abstract
Objectives: To assess survival and prognostic factors among women with epithelial ovarian cancer in Western Saudi Arabia. Methods: A retrospective cohort study was carried out between October 2000 and May 2018, reviewing clinical and pathology data of all women who underwent staging or debulking surgery for epithelial ovarian cancer. Analysis of disease-free survival (DFS), overall survivals (OS) and the associated factors used Kaplan-Meier method in addition to cox multivariate regression. Results: A total of 144 patients were included (median age=49.5 years), with a median follow-up time was 3.4 years. Majority (59.7%) of the patients were diagnosed at an advanced stage (III or IV). The mean (95% CI) DFS was 82.3 (67.8-96.8) months, OS was 96.2 (81.3-111.2) months, and the 5-year survival rate was estimated as 38.9%. Univariate analysis showed that older age, clear cell or papillary carcinoma subtypes, serous type, advanced International Federation of Gynecology and Obstetrics (FIGO) stage and the presence of residual disease were associated with poorer DFS and OS (log rank <0.05). Cox regression showed FIGO stage and residual disease >1cm as the strongest prognostic factors independently associated with DFS and OS. Conclusion: Improving early diagnosis and achieving optimal cytoreduction are the most critical challenges to achieve significant positive impact on survival of women with epithelial ovarian cancer.
Article Type
Research Article
Recommended Citation
Sait, Khalid H.; Alam, Mohammad Z.; Haque, Absarul; Sait, Hesham K.; Sait, Maram K.; and Anfinan, Nisreen M.
(2022)
"Survival and prognostic factors in women treated for epithelial ovarian cancer in western region of Saudi Arabia,"
Saudi Medical Journal: Vol. 43:
Iss.
2, Article 5.
DOI: https://doi.org/10.15537/smj.2022.43.2.20210626
DOWNLOADS
Since April 09, 2026
COinS
